Gary Meininger

Gary Meininger

Directeur Technique/Scientifique/R&D chez SANA BIOTECHNOLOGY, INC.
Health Technology
Consumer Services

Profil

Gary Meininger currently works at Joslin Diabetes Center, Inc., as Director from 2024 and Sana Biotechnology, Inc., as Chief Medical Officer from 2023.
Dr. Meininger also formerly worked at Johnson & Johnson, as Vice President from 2010 to 2019, Vertex Pharmaceuticals, Inc., as Senior Vice President & Head-Clinical Development from 2020 to 2023, and Merck Research Laboratories Massachusetts LLC, as Principal from 2002 to 2010.
Dr. Meininger received his undergraduate degree from State University of New York at Binghamton and doctorate degree from New York University School of Medicine.

Postes actifs de Gary Meininger

SociétésPosteDébut
SANA BIOTECHNOLOGY, INC. Directeur Technique/Scientifique/R&D 10/04/2023
Directeur/Membre du Conseil 01/10/2024

Anciens postes connus de Gary Meininger

SociétésPosteFin
VERTEX PHARMACEUTICALS INCORPORATED Directeur Technique/Scientifique/R&D 01/03/2023
JOHNSON & JOHNSON Corporate Officer/Principal 01/02/2019
Corporate Officer/Principal 01/07/2010
Voir l'expérience en détail de Gary Meininger

Formation de Gary Meininger

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

80

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Gary Meininger
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT